What can pharma companies do to get promising antimicrobials to the frontlines of drug resistance?
According to the report, the race to create antibiotics and antifungals to conquer superbugs is falling perilously short, which the authors say is putting people across the world at risk. However, a shift in research and development (R&D), including …